USD 1.06
(0.0%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 64.32 Million MYR | -93.25% |
2022 | 953.37 Million MYR | -91.41% |
2021 | 11.1 Billion MYR | 289.49% |
2020 | 2.85 Billion MYR | 222.45% |
2019 | 883.99 Million MYR | 4.38% |
2018 | 846.87 Million MYR | 39.9% |
2017 | 605.31 Million MYR | 1.64% |
2016 | 595.54 Million MYR | 7.32% |
2015 | 554.9 Million MYR | 44.71% |
2014 | 383.45 Million MYR | 5.57% |
2013 | 363.21 Million MYR | -5.67% |
2012 | 385.04 Million MYR | 63.74% |
2011 | 235.14 Million MYR | -46.42% |
2010 | 438.88 Million MYR | 17.63% |
2009 | 373.1 Million MYR | 63.95% |
2008 | 227.57 Million MYR | 6.14% |
2007 | 214.4 Million MYR | 26.38% |
2006 | 169.65 Million MYR | 44.44% |
2005 | 117.45 Million MYR | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q3 | -34.3 Million MYR | 15.73% |
2024 Q1 | -59.52 Million MYR | 3.65% |
2024 Q2 | -58.73 Million MYR | 11.53% |
2023 Q3 | -123.14 Million MYR | 21.43% |
2023 Q2 | -156.72 Million MYR | -9.46% |
2023 FY | 64.32 Million MYR | -93.25% |
2023 Q1 | -143.18 Million MYR | -12081.67% |
2023 Q4 | -97 Million MYR | 21.23% |
2022 Q4 | 1.19 Million MYR | 132.83% |
2022 Q2 | 97.7 Million MYR | -55.61% |
2022 Q1 | 220.1 Million MYR | -66.75% |
2022 FY | 953.37 Million MYR | -91.41% |
2022 Q3 | -3.64 Million MYR | -103.73% |
2021 Q4 | 662.06 Million MYR | -74.28% |
2021 Q3 | 2.57 Billion MYR | -30.26% |
2021 Q2 | 3.69 Billion MYR | 21.15% |
2021 Q1 | 3.04 Billion MYR | 40.81% |
2021 FY | 11.1 Billion MYR | 289.49% |
2020 Q3 | 417.02 Million MYR | 201.77% |
2020 Q4 | 2.16 Billion MYR | 418.88% |
2020 Q1 | 132.23 Million MYR | -74.14% |
2020 FY | 2.85 Billion MYR | 222.45% |
2020 Q2 | 138.19 Million MYR | 4.5% |
2019 Q1 | 148.62 Million MYR | -68.57% |
2019 Q2 | 134.89 Million MYR | -9.24% |
2019 Q3 | 89.09 Million MYR | -33.95% |
2019 FY | 883.99 Million MYR | 4.38% |
2019 Q4 | 511.38 Million MYR | 474.0% |
2018 Q3 | 136.55 Million MYR | 15.15% |
2018 Q4 | 472.83 Million MYR | 246.25% |
2018 Q2 | 118.59 Million MYR | 9.67% |
2018 Q1 | 108.13 Million MYR | -69.21% |
2018 FY | 846.87 Million MYR | 39.9% |
2017 Q1 | 81.45 Million MYR | -68.77% |
2017 FY | 605.31 Million MYR | 1.64% |
2017 Q4 | 351.21 Million MYR | 329.73% |
2017 Q3 | 81.72 Million MYR | -10.11% |
2017 Q2 | 90.91 Million MYR | 11.61% |
2016 FY | 595.54 Million MYR | 7.32% |
2016 Q1 | 152.42 Million MYR | -55.17% |
2016 Q3 | 59.96 Million MYR | -50.97% |
2016 Q4 | 260.86 Million MYR | 335.02% |
2016 Q2 | 122.29 Million MYR | -19.76% |
2015 Q4 | 339.97 Million MYR | 268.98% |
2015 Q3 | 92.13 Million MYR | -42.12% |
2015 Q2 | 159.2 Million MYR | 178.86% |
2015 FY | 554.9 Million MYR | 44.71% |
2015 Q1 | 57.09 Million MYR | -75.46% |
2014 Q3 | 47.62 Million MYR | 5.12% |
2014 Q2 | 45.3 Million MYR | -22.33% |
2014 Q1 | 58.32 Million MYR | -71.86% |
2014 FY | 383.45 Million MYR | 5.57% |
2014 Q4 | 232.68 Million MYR | 388.62% |
2013 FY | 363.21 Million MYR | -5.67% |
2013 Q2 | 576.41 Million MYR | -1.4% |
2013 Q4 | 207.24 Million MYR | 481.11% |
2013 Q1 | 584.57 Million MYR | -3.75% |
2013 Q3 | 35.66 Million MYR | -93.81% |
2012 Q3 | 603.29 Million MYR | 9.89% |
2012 FY | 385.04 Million MYR | 63.74% |
2012 Q1 | 554.84 Million MYR | 2.4% |
2012 Q2 | 548.99 Million MYR | -1.05% |
2012 Q4 | 607.32 Million MYR | 0.67% |
2011 Q3 | 535.36 Million MYR | 10.34% |
2011 Q4 | 541.83 Million MYR | 1.21% |
2011 Q2 | 485.2 Million MYR | 0.0% |
2011 FY | 235.14 Million MYR | -46.42% |
2010 FY | 438.88 Million MYR | 17.63% |
2009 FY | 373.1 Million MYR | 63.95% |
2008 FY | 227.57 Million MYR | 6.14% |
2007 FY | 214.4 Million MYR | 26.38% |
2006 FY | 169.65 Million MYR | 44.44% |
2005 FY | 117.45 Million MYR | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
American Medical Technologies Inc. | 1.69 Million USD | -3685.518% |
Ansell Limited | 624.8 Million USD | 89.706% |
Ansell Limited | 624.8 Million USD | 89.706% |
BG Medicine, Inc. | - USD | -Infinity% |
Biotage AB (publ) | 113.94 Million USD | 43.55% |
BioLife Sciences Inc. | - USD | -Infinity% |
CB Scientific, Inc. | 135.05 Thousand USD | -47525.042% |
Psykey, Inc. | 415.97 Thousand USD | -15362.431% |
ConvaTec Group Plc | 1.2 Billion USD | 94.654% |
ConvaTec Group Plc | 1.17 Billion USD | 94.525% |
Encision Inc. | 3.13 Million USD | -1951.045% |
Golden Valley Development, Inc | - USD | -Infinity% |
Hear AtLast Holdings, Inc. | - USD | -Infinity% |
Innovative MedTech Inc. | 794.01 Thousand USD | -8000.623% |
LifePoint, Inc. | -71.35 Thousand USD | 90237.055% |
Medite Cancer Diagnostics, Inc. | -131 Thousand USD | 49199.237% |
Paradigm Medical Industries, Inc. | 525 Thousand USD | -12151.429% |
QuantRx Biomedical Corporation | - USD | -Infinity% |
Remedent, Inc. | 603.24 Thousand USD | -10562.423% |
Reflect Scientific, Inc. | 596.42 Thousand USD | -10684.329% |
SmileDirectClub, Inc. | 275.84 Million USD | 76.683% |
Sector 10, Inc. | - USD | -Infinity% |
Shandong Weigao Group Medical Polymer Company Limited | 900.72 Million USD | 92.859% |
SheerVision, Inc. | 2.17 Million USD | -2856.006% |
United Health Products, Inc. | -4857.00 USD | 1324374.243% |
Vasamed, Inc. | -69.38 Thousand USD | 92796.143% |
Wearable Health Solutions, Inc. | 267.66 Thousand USD | -23930.217% |
Yubo International Biotech Limited | 52.65 Thousand USD | -122060.602% |